PAGS | ||
---|---|---|
OUTLOOK RATING 1..100 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 55 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 87 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PAGS | |
---|---|
RSI ODDS (%) | 2 days ago85% |
Stochastic ODDS (%) | 2 days ago82% |
Momentum ODDS (%) | 2 days ago79% |
MACD ODDS (%) | 2 days ago84% |
TrendWeek ODDS (%) | 2 days ago81% |
TrendMonth ODDS (%) | 2 days ago82% |
Advances ODDS (%) | 12 days ago82% |
Declines ODDS (%) | 6 days ago81% |
BollingerBands ODDS (%) | 2 days ago84% |
Aroon ODDS (%) | 2 days ago88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ULVM | 79.82 | 1.20 | +1.52% |
VictoryShares US Value Momentum ETF | |||
FFIU | 21.74 | 0.17 | +0.80% |
Fieldstone UVA Uncons Md-Trm Fxd Inc ETF | |||
SPXS | 6.23 | 0.03 | +0.48% |
Direxion Daily S&P 500® Bear 3X ETF | |||
GUSA | 48.46 | N/A | N/A |
Goldman Sachs MarketBeta US 1000 Eq ETF | |||
IBRN | 21.32 | N/A | N/A |
iShares Neuroscience and Healthcare ETF |
A.I.dvisor indicates that over the last year, KEMQ has been loosely correlated with PDD. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KEMQ jumps, then PDD could also see price increases.
Ticker / NAME | Correlation To KEMQ | 1D Price Change % | ||
---|---|---|---|---|
KEMQ | 100% | +0.04% | ||
PDD - KEMQ | 59% Loosely correlated | -0.23% | ||
CPNG - KEMQ | 43% Loosely correlated | +1.44% | ||
PAGS - KEMQ | 35% Loosely correlated | -1.20% | ||
DLO - KEMQ | 22% Poorly correlated | +2.33% | ||
MELI - KEMQ | 14% Poorly correlated | +1.66% | ||
More |